{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T05:37:00Z","timestamp":1736314620298,"version":"3.32.0"},"reference-count":68,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2005,6,8]],"date-time":"2005-06-08T00:00:00Z","timestamp":1118188800000},"content-version":"vor","delay-in-days":3828,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am. J. Med. Genet."],"published-print":{"date-parts":[[1994,12,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This article attempts to elucidate the theory and practice of psychopharmacogenetics. Eight working models were identified and characterized with a distinct view of risk factors in the host, the pathophysiology of disease, and the strategies for optimum therapy. The biochemical culprits related to adverse drug reaction in each case can be used to identify a risk and thus contribute to prevention research. Since the phenomenology of these uncommon conditions covers a broad spectrum of neuropsychiatric manifestations, the insights they generated might presage a better understanding of the natural history of a wider range of mental disorders associated with genetic vulnerability. The emerging information suggests that psychopharmacogenetics could be defined from clinical perspectives as multidimensional analysis of genes, drugs, and behaviour for the treatment and prevention of psychiatric disorders. \u00a9 1994 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ajmg.1320540420","type":"journal-article","created":{"date-parts":[[2006,2,4]],"date-time":"2006-02-04T10:56:55Z","timestamp":1139050615000},"page":"391-397","source":"Crossref","is-referenced-by-count":4,"title":["Theory and practice of psychopharmacogenetics"],"prefix":"10.1002","volume":"54","author":[{"given":"Jun\u2010Bi","family":"Tu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,6,8]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"113","volume-title":"The Medical Letter on Drugs and Therapeutics","author":"Abramowicz M","year":"1989"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1091644"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)90537-D"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1177\/070674378903400716"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(59)90423-4"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199005313222204"},{"key":"e_1_2_1_8_1","first-page":"361","article-title":"Clinical trial of \u2018off diet\u2019 older phenylketonurics with a new phenylalanine\u2010free product","volume":"34","author":"Crowley C","year":"1990","journal-title":"J Ment Defic Res"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1177\/070674379403900104"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/34.6.395"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1990.tb08814.x"},{"key":"e_1_2_1_11_1","first-page":"914","article-title":"Porphyria and the dangerous life\u2010threatening drugs","volume":"53","author":"Earles L","year":"1979","journal-title":"S Afr Med J"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.10.9.868"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-7697-6"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.17.2.102"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(12)61934-X"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-198403000-00006"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-193106000-00028"},{"key":"e_1_2_1_18_1","first-page":"247","article-title":"Serotonergic treatment for aggression in a Down's syndrome adult showing signs of Alzheimer's disease","volume":"35","author":"Gedye A","year":"1991","journal-title":"J Ment Defic Res"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199301000-00007"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410270309"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.160.4.439"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(87)90116-X"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2788.1992.tb00494.x"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(90)90517-U"},{"key":"e_1_2_1_25_1","first-page":"1128","article-title":"Psychosis in Down's syndrome treated with amitriptyline","volume":"110","author":"Keegan DL","year":"1974","journal-title":"Can Med Assoc J"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.148.1.85"},{"key":"e_1_2_1_27_1","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1017\/S0317167100038075","article-title":"Chorea","volume":"14","author":"Klawans HL","year":"1987","journal-title":"Can J Neurol Sci"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(78)92217-1"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(56)90869-8"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(64)90104-4"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.148.9.1189"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198111053051902"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199105163242005"},{"volume-title":"Mendelian Inheritance in Mann","year":"1990","author":"McKusick VA","key":"e_1_2_1_34_1"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4684-1277-2"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1957.72980250010016"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199105023241802"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.158.6.850"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(92)90046-3"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)92666-2"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199009063231013"},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)90138-F"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.52.11.1294"},{"volume-title":"Wilson's Disease","year":"1984","author":"Scheinberg IH","key":"e_1_2_1_44_1"},{"key":"e_1_2_1_45_1","first-page":"89","article-title":"Elevated adipose tissue lipoprotein lipase in the pathogenesis of obesity in Prader\u2010Willi syndrome","volume":"92","author":"Schwarcs RS","year":"1979","journal-title":"Trans Assoc Am Physicians"},{"key":"e_1_2_1_46_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.261.21.3126"},{"key":"e_1_2_1_47_1","first-page":"409","article-title":"\u00dcber twce zeldzame kleurstoffen in urine van zieken","volume":"25","author":"Stokvis BJ","year":"1889","journal-title":"Ned Tijdschr Geneeskel"},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.148.6.775"},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.142.12.1430"},{"key":"e_1_2_1_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320480102"},{"key":"e_1_2_1_51_1","first-page":"795","article-title":"Phenylketonuria: The inadvisability of neuroleptic medication","volume":"15","author":"Tu JB","year":"1980","journal-title":"Biol Psychiatry"},{"key":"e_1_2_1_52_1","first-page":"963","article-title":"The inadvisability of neuroleptic medication in Wilson's disease","volume":"16","author":"Tu JB","year":"1981","journal-title":"Biol Psychiatry"},{"key":"e_1_2_1_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(88)90159-X"},{"key":"e_1_2_1_54_1","first-page":"114","article-title":"Diagnosis and treatment studies of patients in asymptomatic stages of Wilson's disease","volume":"4","author":"Tu JB","year":"1968","journal-title":"Birth Defects"},{"key":"e_1_2_1_55_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199211000-00024"},{"key":"e_1_2_1_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.1972.tb02618.x"},{"key":"e_1_2_1_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(89)90130-7"},{"key":"e_1_2_1_58_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01802042"},{"key":"e_1_2_1_59_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-02489-8"},{"key":"e_1_2_1_60_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.153.3.376"},{"key":"e_1_2_1_61_1","first-page":"1","article-title":"Studien \u00fcber porphyrie","volume":"92","author":"Waldenstr\u00f6m J","year":"1937","journal-title":"Acta Med Scand"},{"key":"e_1_2_1_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)90423-0"},{"key":"e_1_2_1_63_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1989.11"},{"key":"e_1_2_1_64_1","first-page":"165","article-title":"Familial occurrence of tardive dyskinesia","volume":"42","author":"Weinhold P","year":"1981","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_65_1","series-title":"WHO Technical Report Series No. 524","volume-title":"Pharmacogenetics","author":"World Heath Organization","year":"1973"},{"key":"e_1_2_1_66_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.138.12.1618"},{"key":"e_1_2_1_67_1","first-page":"588","article-title":"Syndrome of hypotonia\u2010hypomentia\u2010hypogonadism, obesity (HHHO) or Prader\u2010Willi Syndrome","volume":"115","author":"Zellweger H","year":"1968","journal-title":"Am J Dis Child"},{"key":"e_1_2_1_68_1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1176\/ajp.148.2.162","article-title":"Insights into the structure and function of GABA\u2010benzodiazepine receptors: Iron channels and psychiatry","volume":"148","author":"Zorumski CF","year":"1991","journal-title":"Am J Psychiatry"}],"container-title":["American Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajmg.1320540420","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajmg.1320540420","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T16:14:41Z","timestamp":1736266481000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajmg.1320540420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,12,15]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1994,12,15]]}},"alternative-id":["10.1002\/ajmg.1320540420"],"URL":"https:\/\/doi.org\/10.1002\/ajmg.1320540420","archive":["Portico"],"relation":{},"ISSN":["0148-7299","1096-8628"],"issn-type":[{"type":"print","value":"0148-7299"},{"type":"electronic","value":"1096-8628"}],"subject":[],"published":{"date-parts":[[1994,12,15]]}}}